期刊文献+

HPV43/66感染致疣状表皮发育不良一例

A case of epidermodysplasia verruciformis caused by human papillomavirus 43/66 infection
原文传递
导出
摘要 患者男,37岁。因全身多发疣状丘疹、斑片20年,外阴和腹股沟糜烂、渗出2个月就诊。皮肤科检查:全身多发、蚕豆大疣状丘疹,部分融合成片。双侧腹股沟及外阴皮损处糜烂、渗液和结痂。外周血淋巴细胞亚群分析示:CD4+T细胞37.2%,CD8+T细胞43.6%,CD4+/CD8+细胞比值0.85。斑点杂交示:HPV43和66DNA阳性。皮损组织病理:角化过度,表皮疣状增生及假上皮瘤样增生,可见部分凹空细胞,真皮浅层中度淋巴细胞浸润。诊断为疣状表皮发育不良、皮肤感染和细胞免疫功能低下。治疗给予抗感染、肌内注射免疫增强剂和口服阿维A胶囊,治疗15d后外阴和腹股沟皮损表面干燥、变平,并有大量痂屑脱落,而躯干和四肢皮损无明显变化。目前患者仍在随访中。 A 37-year-old male was hospitalized due to widespread verrucous papules and patches over the body surface for over 20 years as well as erosive and exudative lesions in the inguinal and vulvar regions for two months. Skin examination revealed numerous round or polygonal, bean-sized verrueous papules on the face, trunk and extremities, with some coalescing into patches. The lesions on bilateral inguinal and vulvar areas were erosive and exudative with dirty crusts. Analysis of peripheral blood lymphocyte subsets showed that CD4~ T cells amounted to 37.2%, CD8+ T cells 43.6%, and the CD4~/CD8+ T cell ratio was 0.85. The tissue specimen was positive for human papillomavirus (HPV) 43 and 66 DNA by dot-blot hybridization. Histopathological examination indicated hyperkeratosis, verrueous hyperplasia and pseudo-epitheliomatous hyperplasia of the epidermis with the presence of some koilocytes, and moderate infiltration of the upper dermis with lymphocytes. He was diagnosed with epidermodysplasia verruciformis and cutaneous infection with non-specific cellular immune dysfunction, and given anti-infection therapy, intramuscular immunoenhancing agents and oral acitretin. After 15 days of treatment, the condition in the vulval and inguinal region greatly improved with shedding of crusts and desquamation, but the lesions on the trunk and extremities experienced no obvious changes. At the time of this writing, the patient was still followed up.
出处 《国际皮肤性病学杂志》 2014年第1期3-4,共2页 International Journal of Dermatology and Venereology
关键词 表皮发育不良 疣状 人乳头瘤病毒43 66 感染 Epidermodysplasia verruciformis Human papillomavirus 43/66 Infection
  • 相关文献

参考文献5

  • 1王培光,杨森,张学军.疣状表皮发育不良研究进展[J].国外医学(遗传学分册),2005,28(6):372-375. 被引量:8
  • 2Ramoz N, Taieb A, Rueda LA, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two suscep- tibility loci mapped to chromosome regions 2p21-p24 and 17q25 [J]. J Invest Dermatol, 2000, 114(6): 1148-1153.
  • 3Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses [J]. Semin lmmunol, 2006, 18(6): 362-374.
  • 4Gormley RH, Kovarik CL. Dermatologie manifestations of HPV in HIV-infeeted individu',ds [Jl. Curt HIV/AIDS Rep, 2009, 6 (3): 130-138.
  • 5Anadolu R, Oskay T, Erdem C, et al. Treatment of epidermodys- plasia verruciformis with a combination of aeitretin and interferon alfa-2a[J]. J Am Aead Dermatol, 2001, 45(2): 296-299.

二级参考文献22

  • 1Sehgal VN, Luthra A, Bajaj P. Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol, 2002,41:500-503.
  • 2Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol, 1984,83:18-25.
  • 3Ishiji T, Kawase M, Honda M, et al. Distinctive distribution of human papillomavirus type 16 and 20 DNA in the tonsillar and the skin carcinomas of a patient with epidermodysplasia verruciformis. Br J Dermatol, 2000,143:1005-1010.
  • 4Alpsoy E, Ciftcioglu MA, Keser I, et al. Epidermodysplasia verruciformis associated with neurofibromatosis type 1: coincidental association or model for understanding the underlying mechanism of the disease? Br J Dermatol, 2002,146:503-507.
  • 5De Oliveria WR, He Q, Rady PL, et al. HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV25. J Cutan Med Surg, 2004,8:110-115.
  • 6Morrison C, Eliezri Y, Magro C, et al. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol, 2002,29:480-499.
  • 7De Oliveria WR, Carrasco S, Neto CF, et al. Nonspecific cell-mediated immunity in patients with epidermodysplsia verruciformis. J Dermatol, 2003,30:203-209.
  • 8Haftek M, Jablonska S, Szymanczyk J, et al. Langerhans cells in epidermodysplasia verruciformis. Dermaologica, 1987,174:173-179.
  • 9De Oliveria WR, Rady PL, Grady J, et al. Polymorphism of the interleukin 10 gene promoter in patients from Brazil with epidermodysplsia verruciformis. J Am Acad Dermatol, 2003,49:639-643.
  • 10Majewski S, Huzelmann N, Nischt R, et al. TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis. J Invest Dermatol, 1991,97:862-867.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部